What is Sumatriptan?
Category: Prescription Drugs
Most popular types: Imitrex Imigran Imitrex Nasal Show all
Sumatriptan is a selective serotonin receptor agonist used to relieve the symptoms of migraine headaches. It works by narrowing blood vessels in the head and stopping pain signals from being sent to the brain. Sumatriptan does not prevent migraine attacks.
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Migraine | 3159 | 286 | |
| Migraine headaches | 1025 | 233 | |
| Cluster headaches | 552 | 59 | |
| Headaches | 38 | 5 | |
| General health | 6 | 3 |
- Major
- Moderate
- Slight
- None
- Can't tell
Side effects
Side effects as an overall problem
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 71 | |
| Moderate | 93 | |
| Mild | 148 | |
| None | 213 |
Commonly reported side effects and conditions associated with Sumatriptan
| Side effect | Patients | Percentage |
|---|---|---|
| Nausea | 33 | |
| Sleepiness | 19 | |
| Fatigue | 14 | |
| Dizziness | 13 | |
| Tiredness | 13 | |
| Chest tightness | 11 |
Why patients stopped taking Sumatriptan
Multiple reasons could be selected
| Reason | Patients | Percentage |
|---|---|---|
| Did not seem to work | 196 | |
| Side effects too severe | 139 | |
| Other | 87 | |
| Doctor's advice | 86 | |
| Expense | 43 | |
| Course of treatment ended | 21 | |
| Change in health plan coverage | 11 | |
| Personal research | 10 |
Duration
Stopped taking Sumatriptan
| Duration | Patients | Percentage |
|---|---|---|
| Less than 1 month | 137 | |
| 1 - 6 months | 64 | |
| 6 months - 1 year | 51 | |
| 1 - 2 years | 50 | |
| 2 - 5 years | 70 | |
| 5 - 10 years | 49 | |
| 10 years or more | 30 |
What people switch to and from
Patients started taking Sumatriptan after stopping:
| Treatment | Patients | Percentage |
|---|---|---|
| Rizatriptan (Maxalt) | 17 | |
| Zolmitriptan (Zomig) | 15 | |
| Eletriptan (Relpax) | 11 | |
| Topiramate (Topamax) | 6 | |
| Frovatriptan (Frova) | 5 |
Patients stopped taking Sumatriptan and switched to:
| Treatment | Patients | Percentage |
|---|---|---|
| Rizatriptan (Maxalt) | 44 | |
| Topiramate (Topamax) | 19 | |
| Zolmitriptan (Zomig) | 17 | |
| Eletriptan (Relpax) | 10 | |
| Botulinum Toxin Type A (Botox) | 9 |
Last updated: